inTRANSITION FAQs
Frequently Asked Questions
Tell us what you're looking for to find questions and answers about your topic.
Recent FAQs
inTRANSITION FAQs for Service Members and Veterans
Mental Health by the Numbers FAQs
Airborne Hazards and Open Burn Pit Registry: Eligibility and Enrollment
Airborne Hazards and Open Burn Pit Registry: General Information
Individual Longitudinal Exposure Record
MHS Modified Payment and Waiver Program: Overseas Information
MHS Modified Payment and Waiver Program: Implementation Timeline
MHS Modified Payment and Waiver Program: Billing Delays
MHS Modified Payment and Waiver Program: Eligibility Requirements
Popular FAQs
Joint Longitudinal Viewer
The Brandon Act
Individual Longitudinal Exposure Record
Airborne Hazards and Open Burn Pit Registry: Eligibility and Enrollment
TRICARE Formulary
Prescription Drug Monitoring Program FAQs
Project 112 SHAD
Joint Health Information Exchange
VA/DOD Clinical Practice Guideline for Tinnitus
Frequently Asked Questions for Identifiers
We found 869 items
Prior Authorization Medication List
Most recent Prior Authorization Medication List.
Basic/Extended Core Formulary
Most recent Basic/Extended Core Formulary document.
Tier4/Not Covered Drug List
Most recent Tier4/Not Covered Drug List.
Specialty Drug List
Most recent version of the Specialty Drug list.
Non-Formulary Drug List
Most recent non-formulary drug list.
Maintenance Drug List
Most recent Maintenance Drug List.
UF BAP Minutes and EXSUM September 23 2026
Provides a summary of proceedings, votes, and recommendations from the UF BAP committee meeting on P&T conclusions from August 2026
UF BAP Meeting Information September 23 2026
Provides information for the BAP meeting access
UF BAP Meeting Agenda September 23 2006
Provides a listing of topics to be discussed for the BAP meeting
UF BAP Meeting Background Document September 23rd 2026
Provides a summary of decisions and recommendations made by P&T committee to be discussed at the BAP meeting
UF BAP Meeting EXSUM and Minutes June 22 Day 1
Details recommendations and decisions made by P&T Committee and the proceedings of the BAP panel surrounding these recommendations as well as final votes and actions
UF BAP Meeting Minutes June 24th Day 3
Details recommendations and decisions from the P&T committee meeting and the votes and discussion surrounding these recommendations by the BAP panel
UF BAP Meeting Minutes June 23rd Day 2
Contains recommendations from the P&T committee meeting and proceedings from the BAP panel outlining votes and final actions
P&T Minutes - August 2026
Provides a summary of clinical conclusions for drug class reviews, new drug formulary placement recommendations, and utilization management conclusions from the August 2026 P and T committee meeting.
UF BAP Background Document for May 2026
Contains summary of P&T committee proceedings, recommendations and conclusions from May 2026
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil View the external links disclaimer.